Kenji Otsuka

431 total citations
32 papers, 321 citations indexed

About

Kenji Otsuka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Kenji Otsuka has authored 32 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Kenji Otsuka's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Kenji Otsuka is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Kenji Otsuka collaborates with scholars based in Japan and United States. Kenji Otsuka's co-authors include Yasuhiko Nishioka, Hirokazu Ogino, Hiroshi Nokihara, Hisatsugu Goto, Masaki Hanibuchi, Atsuro Saijo, Atsushi Mitsuhashi, Kinji Ohno, Mamoru Aoki and Yuko Toyoda and has published in prestigious journals such as The Journal of Immunology, Brain Research and Cell Reports.

In The Last Decade

Kenji Otsuka

32 papers receiving 316 citations

Peers

Kenji Otsuka
Nam K. Yoon United States
Yimin Xu China
Austen Knapp United States
Zita Reisz Hungary
Nam K. Yoon United States
Kenji Otsuka
Citations per year, relative to Kenji Otsuka Kenji Otsuka (= 1×) peers Nam K. Yoon

Countries citing papers authored by Kenji Otsuka

Since Specialization
Citations

This map shows the geographic impact of Kenji Otsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Otsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Otsuka more than expected).

Fields of papers citing papers by Kenji Otsuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Otsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Otsuka. The network helps show where Kenji Otsuka may publish in the future.

Co-authorship network of co-authors of Kenji Otsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Otsuka. A scholar is included among the top collaborators of Kenji Otsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Otsuka. Kenji Otsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanibuchi, Masaki, Eiji Takeuchi, Takashi Haku, et al.. (2023). A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer. Thoracic Cancer. 14(32). 3232–3239. 2 indexed citations
2.
Mitsuhashi, Atsushi, Kazuya Koyama, Hirokazu Ogino, et al.. (2023). Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade. Cell Reports. 42(3). 112162–112162. 12 indexed citations
3.
Nokihara, Hiroshi, Hirokazu Ogino, Atsushi Mitsuhashi, et al.. (2022). Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion. BMC Cancer. 22(1). 597–597. 3 indexed citations
4.
Morita, Yutaka, Atsuro Saijo, Hiroshi Nokihara, et al.. (2022). Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer. Thoracic Cancer. 13(7). 1079–1082. 5 indexed citations
6.
Nokihara, Hiroshi, et al.. (2021). Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma. BMC Pulmonary Medicine. 21(1). 373–373. 3 indexed citations
7.
Sako, Masahiro, Hiroshi Nokihara, Kensuke Kondo, et al.. (2021). A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab. Thoracic Cancer. 13(1). 129–132. 4 indexed citations
8.
Mitsuhashi, Atsushi, Kensuke Kondoh, Kazuki Horikawa, et al.. (2021). Programmed death (PD)‐1/PD‐ligand 1 blockade mediates antiangiogenic effects by tumor‐derived CXCL10/11 as a potential predictive biomarker. Cancer Science. 112(12). 4853–4866. 11 indexed citations
9.
Otsuka, Kenji, Atsushi Mitsuhashi, Hisatsugu Goto, et al.. (2020). Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells. Lung Cancer. 146. 86–96. 16 indexed citations
10.
Ogino, Hirokazu, Masaki Hanibuchi, Satoshi Sakaguchi, et al.. (2018). The clinical features of older patients with lung cancer in comparison with their younger counterparts. Respiratory Investigation. 57(1). 40–48. 4 indexed citations
11.
Hanibuchi, Masaki, Soji Kakiuchi, Shinji Atagi, et al.. (2018). A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease. Lung Cancer. 125. 93–99. 20 indexed citations
13.
Kakiuchi, Soji, Masaki Hanibuchi, Atsuro Saijo, et al.. (2016). Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1. Respiratory Investigation. 55(2). 145–152. 20 indexed citations
14.
Otsuka, Kenji, et al.. (2011). Study on Rapid Analysis Method of Pesticide Contamination in Processed Foods by GC-MS and GC-FPD. Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi). 52(4). 226–236. 4 indexed citations
15.
Otsuka, Kenji, et al.. (2009). Survey of Pesticide Residues in Imported Vegetable Products (1992. 4-2006. 3). Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi). 50(3). 146–152. 1 indexed citations
16.
Otsuka, Kenji, et al.. (2002). Effect of Magnesium Powder Addition on Corrosion Resistance of MgO-C Bricks. Taikabutsu overseas. 22(151). 366–370. 1 indexed citations
17.
Otsuka, Kenji, et al.. (1998). Joining of Alumina to Spheroidal Graphite Cast Irons Using Active Filler Metal. Journal of Japan Foundry Engineering Society. 70(12). 891–896. 1 indexed citations
18.
Okada, N, et al.. (1996). Expression of Decay-accelerating Factor on CD8-positive Lymphocytes as an Index of Aging and of Host Defense Function.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 33(8). 580–585. 1 indexed citations
19.
Otsuka, Kenji, et al.. (1994). A Case of Metastatic Thyroid Carcinoma and a Review of Related Literature Reported in Japan.. Nihon Kikan Shokudoka Gakkai Kaiho. 45(6). 468–477. 5 indexed citations
20.
Mori, Kazuhisa, Hitoshi Imaizumi, Shoji Sakano, et al.. (1994). Severe bothrop bite with ocular signs. Evaluation of the mechanism of ocular signs.. Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine. 5(7). 699–705. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026